These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24612978)

  • 21. Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals.
    Morizane Y; Morimoto N; Fujiwara A; Kawasaki R; Yamashita H; Ogura Y; Shiraga F
    Jpn J Ophthalmol; 2019 Jan; 63(1):26-33. PubMed ID: 30255397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ophthalmic Conditions Associated with Inpatient Falls among Veterans.
    Campagna G; Chamberlain P; Orengo-Nania S; Biggerstaff K; Khandelwal S
    Optom Vis Sci; 2018 Dec; 95(12):1114-1119. PubMed ID: 30451809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Visual impairment in children born at full term from 1972 through 1989 in Finland.
    Rudanko SL; Laatikainen L
    Ophthalmology; 2004 Dec; 111(12):2307-12. PubMed ID: 15582091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Authors' reply to Ahmad SR: "Adverse drug reaction reporting by patients: an overview of fifty countries".
    Margraff F; Bertram D
    Drug Saf; 2015 Jan; 38(1):111. PubMed ID: 25414076
    [No Abstract]   [Full Text] [Related]  

  • 25. Adverse drug reactions in hospital and in the community.
    D'Arcy PF
    Adverse Drug React Toxicol Rev; 1997 Jun; 16(2):95-101. PubMed ID: 9359931
    [No Abstract]   [Full Text] [Related]  

  • 26. Drug makers' adverse event reports are often incomplete, US report finds.
    McCarthy M
    BMJ; 2015 Feb; 350():h651. PubMed ID: 25652561
    [No Abstract]   [Full Text] [Related]  

  • 27. Visual impairment, coping strategies and impact on daily life: a qualitative study among working-age UK ex-service personnel.
    Stevelink SA; Malcolm EM; Fear NT
    BMC Public Health; 2015 Nov; 15():1118. PubMed ID: 26563137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Five-year change in visual acuity and incidence of visual impairment: the Blue Mountains Eye Study.
    Foran S; Mitchell P; Wang JJ
    Ophthalmology; 2003 Jan; 110(1):41-50. PubMed ID: 12511344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Applying DoTS adverse drug reactions classification to reports from hospital stimulated reporting.
    Farcas A; Bulik NB; Popa A; Mensah Achampong A; Bucsa C; Mogosan C
    Eur J Clin Pharmacol; 2019 Mar; 75(3):433-435. PubMed ID: 30415300
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevalence of impairment of visual function in European drivers.
    van Rijn LJ; Nischler C; Michael R; Heine C; Coeckelbergh T; Wilhelm H; Grabner G; Barraquer RI; van den Berg TJ
    Acta Ophthalmol; 2011 Mar; 89(2):124-31. PubMed ID: 19832733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of macular holes as cause for visual impairment. The Beijing Eye Public Healthcare Project.
    Xu L; You QS; Wang YX; Liang QF; Cui TT; Yang XH; Yang H; Jonas JB
    Acta Ophthalmol; 2013 Mar; 91(2):e157-8. PubMed ID: 23425112
    [No Abstract]   [Full Text] [Related]  

  • 32. Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project.
    VanNewkirk MR; Weih L; McCarty CA; Taylor HR
    Ophthalmology; 2001 May; 108(5):960-7. PubMed ID: 11320028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological investigations following an adverse reaction to oxybuprocaine eye drops.
    Sewell WA; Croucher JJ; Bird AG
    Br J Ophthalmol; 1999 May; 83(5):632. PubMed ID: 10917687
    [No Abstract]   [Full Text] [Related]  

  • 34. Statistical methods for the analysis of adverse event data.
    Kieser M
    Pharm Stat; 2016 Jul; 15(4):290-1. PubMed ID: 27324410
    [No Abstract]   [Full Text] [Related]  

  • 35. Prevalence of visual problems in a rural population of Kenya.
    Signes-Soler I; Piñero DP; Javaloy J
    Acta Ophthalmol; 2013 Mar; 91(2):e165-6. PubMed ID: 22974434
    [No Abstract]   [Full Text] [Related]  

  • 36. Proton-pump inhibitor use is associated with a broad spectrum of neurological adverse events including impaired hearing, vision, and memory.
    Makunts T; Alpatty S; Lee KC; Atayee RS; Abagyan R
    Sci Rep; 2019 Nov; 9(1):17280. PubMed ID: 31754136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in Visual Health Inequalities in Childhood Through Associations of Visual Function With Sex and Social Position Across 3 UK Birth Cohorts.
    Bountziouka V; Cumberland PM; Rahi JS
    JAMA Ophthalmol; 2017 Sep; 135(9):954-961. PubMed ID: 28796860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Underreporting of suspected adverse drug reactions to newly marketed ("black triangle") drugs in general practice: observational study.
    Martin RM; Kapoor KV; Wilton LV; Mann RD
    BMJ; 1998 Jul; 317(7151):119-20. PubMed ID: 9657787
    [No Abstract]   [Full Text] [Related]  

  • 39. [Visual impairment and blindness in children in a Malawian school for the blind].
    Schulze Schwering M; Nyrenda M; Spitzer MS; Kalua K
    Klin Monbl Augenheilkd; 2013 Aug; 230(8):820-4. PubMed ID: 23959513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visual impairment in children born prematurely from 1972 through 1989.
    Rudanko SL; Fellman V; Laatikainen L
    Ophthalmology; 2003 Aug; 110(8):1639-45. PubMed ID: 12917186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.